[go: up one dir, main page]

TR200102781T2 - Yeni bileşikler - Google Patents

Yeni bileşikler

Info

Publication number
TR200102781T2
TR200102781T2 TR2001/02781T TR200102781T TR200102781T2 TR 200102781 T2 TR200102781 T2 TR 200102781T2 TR 2001/02781 T TR2001/02781 T TR 2001/02781T TR 200102781 T TR200102781 T TR 200102781T TR 200102781 T2 TR200102781 T2 TR 200102781T2
Authority
TR
Turkey
Prior art keywords
polypeptides
new compounds
polynucleotides
cancers
colon
Prior art date
Application number
TR2001/02781T
Other languages
English (en)
Inventor
Elvire Maric Bruck Claudine
Cassart Jean-Pol
Coche Thierry
Vinals Y De Bassols Carlota
Original Assignee
Smithkline Beecham Biologicals S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9905607.9A external-priority patent/GB9905607D0/en
Priority claimed from GBGB9920590.8A external-priority patent/GB9920590D0/en
Application filed by Smithkline Beecham Biologicals S. A. filed Critical Smithkline Beecham Biologicals S. A.
Publication of TR200102781T2 publication Critical patent/TR200102781T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Bu bulusta, CASB618 polipeptidler ve polinükleotidler ve bu polipeptidlerin rekombinant tekniklere üretilmesine iliskin yöntemler açiklanmaktadir. Ayrica, CASB618 polipeptidlerin ve polinükleotidlerin, kanserlerin, özellikle over (yumurtalik) ve kolon (kalin bagirsak) kanserlerinin, otoimmün hastaliklarin ve bunlarla ilgili tablolarin teshisinde ve bu hastaliklarin önleyici ve iyilestirici tedavisinde kullanilacak asilarin hazirlanmasinda kullanimina iliskin yöntemler de açiklanmaktadir.
TR2001/02781T 1999-03-11 2000-03-09 Yeni bileşikler TR200102781T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905607.9A GB9905607D0 (en) 1999-03-11 1999-03-11 Novel compounds
GBGB9920590.8A GB9920590D0 (en) 1999-09-01 1999-09-01 Novel compounds

Publications (1)

Publication Number Publication Date
TR200102781T2 true TR200102781T2 (tr) 2002-01-21

Family

ID=26315257

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02781T TR200102781T2 (tr) 1999-03-11 2000-03-09 Yeni bileşikler

Country Status (22)

Country Link
US (2) US7470782B2 (tr)
EP (1) EP1165778B1 (tr)
JP (1) JP2002538787A (tr)
KR (1) KR100674784B1 (tr)
CN (1) CN100430478C (tr)
AT (1) ATE342727T1 (tr)
AU (1) AU756398B2 (tr)
BR (1) BR0008917A (tr)
CA (1) CA2366147A1 (tr)
CZ (1) CZ20013268A3 (tr)
DE (1) DE60031383T2 (tr)
DK (1) DK1165778T3 (tr)
ES (1) ES2273670T3 (tr)
HK (1) HK1044794B (tr)
HU (1) HUP0200366A2 (tr)
IL (2) IL145047A0 (tr)
NO (1) NO20014293L (tr)
NZ (1) NZ513838A (tr)
PL (1) PL350991A1 (tr)
PT (1) PT1165778E (tr)
TR (1) TR200102781T2 (tr)
WO (1) WO2000053748A2 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811574B2 (en) 2000-02-23 2010-10-12 Glaxosmithkline Biologicals S.A. Tumour-specific animal proteins
KR100919916B1 (ko) 2000-02-23 2009-10-07 글락소스미스클라인 바이오로지칼즈 에스.에이. 종양 특이적 동물 단백질
JP2009529876A (ja) * 2006-03-14 2009-08-27 ゲニゾン バイオサイエンシス インコーポレイテッド 核酸を配列決定するための方法および手段
EA200802242A1 (ru) 2006-06-02 2009-08-28 Глаксосмитклайн Байолоджикалс С.А. Способ определения того, будет или не будет пациент респондером на иммунотерапию
SI2148697T1 (sl) 2007-05-24 2013-01-31 Glaxosmithkline Biologicals S.A. Liofilizirani sestavek, ki vsebuje CpG in WT-1
SG176220A1 (en) 2009-05-27 2011-12-29 Glaxosmithkline Biolog Sa Casb7439 constructs
GB0917457D0 (en) 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688657A (en) * 1988-03-31 1997-11-18 International Bio-Immune Systems, Inc. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5840871A (en) * 1997-01-29 1998-11-24 Incyte Pharmaceuticals, Inc. Prostate-associated kallikrein
GB9806164D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
GB9806095D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
US7105315B2 (en) * 1999-06-16 2006-09-12 Incyte Genomics, Inc. Transmembrane protein differentially expressed in cancer
WO2000056891A2 (en) * 1999-03-22 2000-09-28 Incyte Pharmaceuticals, Inc. Human transmembrane proteins
CA2371172A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 50 human secreted proteins

Also Published As

Publication number Publication date
HK1044794A1 (en) 2002-11-01
NZ513838A (en) 2003-02-28
PL350991A1 (en) 2003-02-24
HUP0200366A2 (en) 2002-06-29
CA2366147A1 (en) 2000-09-14
NO20014293L (no) 2001-11-12
DK1165778T3 (da) 2007-02-12
HK1044794B (en) 2007-05-18
NO20014293D0 (no) 2001-09-04
CN1370231A (zh) 2002-09-18
EP1165778A2 (en) 2002-01-02
DE60031383T2 (de) 2007-11-15
WO2000053748A3 (en) 2001-01-11
US20060052593A1 (en) 2006-03-09
ATE342727T1 (de) 2006-11-15
CZ20013268A3 (cs) 2002-02-13
IL145047A0 (en) 2002-06-30
JP2002538787A (ja) 2002-11-19
EP1165778B1 (en) 2006-10-18
CN100430478C (zh) 2008-11-05
AU3287700A (en) 2000-09-28
KR20020008125A (ko) 2002-01-29
AU756398B2 (en) 2003-01-09
IL145047A (en) 2008-11-03
WO2000053748A2 (en) 2000-09-14
DE60031383D1 (de) 2006-11-30
BR0008917A (pt) 2002-01-15
ES2273670T3 (es) 2007-05-16
US20090202577A1 (en) 2009-08-13
PT1165778E (pt) 2007-01-31
KR100674784B1 (ko) 2007-01-25
US7470782B2 (en) 2008-12-30

Similar Documents

Publication Publication Date Title
TR200102577T2 (tr) Kanser Tedavisi için Casb616 Polipeptid ve Polinücleotidlerin kullanımı
TR199901174T2 (tr) Yeni heterosiklilmetil-ikameli pirazol türevleri.
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
TR200100149T2 (tr) Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
TR200003347T2 (tr) Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler
TR200102781T2 (tr) Yeni bileşikler
PE20010516A1 (es) Peptidos ciclicos con afinidad mejorada por los receptores de somatostatina
DE60118359D1 (de) Humanische pellino-polypeptide
TR199902094T2 (tr) 3-Heteroareil-4(3H)-kinazolinonlarin atropizomerleri.
TR200102745T2 (tr) Yeni bileşikler
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
DE69918446D1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
DE60038955D1 (de) AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47
TR200003608T2 (tr) Moraxella Catarrhalis'e ait BASB027 proteinleri ve genleri.
ATE303442T1 (de) Verbindungen aus moraxella catarrhalis
ATE421993T1 (de) Humane carboxypeptidasen und diese kodierende polynukleotide
ATE454452T1 (de) Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
DE60034463D1 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
GB0025170D0 (en) Novel compounds
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
ATE311458T1 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
GB9704046D0 (en) Arrestable therapeutic
DE60039303D1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis